Hi Abobo, the last chance is an emergency approval from the FDA... what's the chance of that happening? The report to the president mentioned it, but I guess they have LANI that can be nebulised.
It will be interesting to see what Biota decide to invest in, it would be nice to develop anti-virals for the flu with different mechanisms of action.